Related Experiment Video
Updated: May 17, 2026

03:43
Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
Published on: September 13, 2022
The vaginally assisted laparoscopic sacrocolpopexy: a pilot study.
Stavros Athanasiou1, Themos Grigoriadis, Ioannis Chatzipapas
1First Department of Obstetrics & Gynecology, Urogynecology Unit, University of Athens, 98A Vas. Sofias Avenue, 11528, Athens, Greece. stavros.athanasiou@gmail.com
International Urogynecology Journal
|October 19, 2012
Summary
Vaginally assisted laparoscopic sacrocolpopexy (VALS) is a safe, minimally invasive surgical option for severe uterovaginal prolapse (UVP). The procedure showed significant anatomical and functional improvements in women after 12 months.
Area of Science:
- Urogynecology
- Minimally Invasive Surgery
- Pelvic Organ Prolapse
Background:
- Severe uterovaginal prolapse (UVP) significantly impacts women's quality of life.
- Surgical interventions are often necessary for severe cases of pelvic organ prolapse (POP).
Purpose of the Study:
- To assess the efficacy and safety of the vaginally assisted laparoscopic sacrocolpopexy (VALS) technique.
- To evaluate short-term anatomical and functional outcomes in women with severe UVP undergoing VALS.
Main Methods:
- A prospective pilot study included 27 women with severe UVP.
- Surgical technique involved a combined vaginal and laparoscopic approach with mesh placement.
- Preoperative and 12-month postoperative assessments used ICS POP-Q and ICIQ-VS.
Main Results:
- VALS was successfully performed in all patients with significant improvement in POP-Q points (except TVL).
- Statistically significant improvements were observed in vaginal symptoms and overall quality of life (ICIQ-VS).
- A trend towards improvement in sexual matters was noted, though not statistically significant.
Conclusions:
- Vaginally assisted laparoscopic sacrocolpopexy (VALS) is a valid and safe minimally invasive surgical option for severe UVP.
- The technique offers encouraging short-term anatomical and functional outcomes for patients.

